January 8, 2025—Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) laser-based platform for the treatment of coronary and peripheral artery disease (PAD). Boston Scientific anticipates the transaction to be completed in the first half of 2025, subject to customary closing conditions.